A method for removing contaminants from an aqueous solution is provided. The method includes contacting the aqueous solution with steam-activated carbon nanoparticles obtained from oil fly ash and/or date palm fronds under conditions sufficient to adsorb contaminants to the carbon nanoparticles, wherein the carbon nanoparticles are formed into pellets or coated on a fabric sheet. Fabric sheets coated with the carbon nanoparticles are also provided.
C02F 1/28 - Treatment of water, waste water, or sewage by sorption
B01J 20/20 - Solid sorbent compositions or filter aid compositionsSorbents for chromatographyProcesses for preparing, regenerating or reactivating thereof comprising inorganic material comprising free carbonSolid sorbent compositions or filter aid compositionsSorbents for chromatographyProcesses for preparing, regenerating or reactivating thereof comprising inorganic material comprising carbon obtained by carbonising processes
B01J 20/28 - Solid sorbent compositions or filter aid compositionsSorbents for chromatographyProcesses for preparing, regenerating or reactivating thereof characterised by their form or physical properties
B01J 20/30 - Processes for preparing, regenerating or reactivating
A method for removing contaminants from an aqueous solution is provided. The method includes contacting the aqueous solution with steam-activated carbon nanoparticles obtained from oil fly ash and/or date palm fronds under conditions sufficient to adsorb contaminants to the carbon nanoparticles, wherein the carbon nanoparticles are formed into pellets or coated on a fabric sheet. Fabric sheets coated with the carbon nanoparticles are also provided.
C02F 1/28 - Treatment of water, waste water, or sewage by sorption
B01J 20/20 - Solid sorbent compositions or filter aid compositionsSorbents for chromatographyProcesses for preparing, regenerating or reactivating thereof comprising inorganic material comprising free carbonSolid sorbent compositions or filter aid compositionsSorbents for chromatographyProcesses for preparing, regenerating or reactivating thereof comprising inorganic material comprising carbon obtained by carbonising processes
B01J 20/28 - Solid sorbent compositions or filter aid compositionsSorbents for chromatographyProcesses for preparing, regenerating or reactivating thereof characterised by their form or physical properties
B01J 20/30 - Processes for preparing, regenerating or reactivating
Systems and methods are disclosed herein for pathogen detection employing a lateral flow assay (LFA) device or ELISA assay, e.g. for detecting SARS-COV-2, the virus that causes COVID-19, in a sample. The LFA device includes a nitrocellulose membrane mounted on a solid support, a sample pad for receiving a sample, a conjugate pad containing gold nanoparticles conjugated to heavy chain antibodies (HcAbs), and an absorbent pad at the end of the device.
Three compounds having a common molecular template of 2-(5-(N-acylamino)pyridin-2-yl)-N-benzylacetamide (Compounds I, II and I) are identified as potential anticancer therapeutic agents, and for the treatment of Acute Myeloid Leukemia (AML) in particular. Compound I was specifically designed to target AML cells, inhibit growth, and induce cell death. Compound I demonstrated a dose-dependent effect on AML cell lines HL-60, Mv4-11, KG-1a, and K562.
A61K 31/444 - Non-condensed pyridinesHydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. amrinone
A61K 31/443 - Non-condensed pyridinesHydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
A61P 35/02 - Antineoplastic agents specific for leukemia
5.
Aryl-1,2,3-triazole compounds, pharmaceutical composition thereof and method for treatment of breast cancer
Compounds belonging to the group of N-benzyl-2-(4-(4-substituted-1H-1,2,3-triazol-1-yl)phenylacetamides have cytotoxic activities against MCF7 breast cancer cells, and are useful in therapeutic regimes for breast cancer. The N-benzyl-2-(4-(4-substituted-1H-1,2,3-triazol-1-yl)phenylacetamides also have beneficial effects on BAX, BCL-2, MCL-1 and MAPK pathways within MCF& breast cancer cells.
C07D 405/12 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
6.
PRODUCTION OF ELISA REAGENTS AND VACCINES BY 'ONE PROCESS'
The invention generally relates to a novel ‘One Process’ for production of polypeptides comprising an anti-idiotypic, mirror image of the antigenic determinants of an agent of interest such as a disease-causing agent. In particular, the polypeptides are used to pre-treat samples prior to indirect ELISA assays and in its incorporation in vaccines. When used in indirect ELISA assays, the result is a significant reduction in false positives, while its inclusion in vaccines provides an additive induction of immunity in humans and different animal species by the proteinaceous mirror image of weak immunogens including, lipid, carbohydrate, and low molecular weight molecules of the agent of interest. The incorporation of anti-idiotypes produced by the ‘One Process’ in vaccines induces antibodies that is used in cocktail of therapeutics for treatment of injurious antigens and autoimmune reactions in humans and animals.
2 at 393 K, and a Seebeck value of 24 to 27 μV/K at 233 K and 30 to 34 μV/K at 393 K. The thermoelectric nanocomposite may include milled, acid-treated oil fly ash. Also, a method of forming the thermoelectric nanocomposite. The thermoelectric nanocomposite may be used in a thermoelectric device.
Systems and methods are disclosed herein for pathogen detection employing a lateral flow assay (LFA) device, e.g. for detecting SARS-CoV-2, the virus that causes COVID-19, in a sample. The LFA device includes a nitrocellulose membrane mounted on a solid support, a sample pad for receiving a sample, a conjugate pad containing gold nanoparticles conjugated to heavy chain antibodies (HcAbs), and an absorbent pad at the end of the device.
A method of making an array of vertically-aligned CNT bundles includes dispersing iron oxide nanoparticles in a solvent to form a suspension. The method further includes dipping a TiN-coated substrate in the suspension and removing to form a suspension-coated substrate. The method also involves drying the suspension-coated substrate by evaporating the solvent from the suspension-coated substrate to form a first sample. Furthermore, the method includes treating the first sample by microwave plasma under hydrogen flow at 500 degrees centigrade (° C.) to 700° C. to form a pre-treated sample followed by treating the pre-treated sample by microwave plasma under methane flow at 500° C. to 700° C. to form the vertically-aligned carbon nanotube bundles.
A method of generating oxygen including applying a potential of from 0.1 volts (V) to 2 V to an electrochemical cell and the electrochemical cell is at least partially submerged in an aqueous solution. On application of the potential, the aqueous solution is oxidized forming the oxygen. The electrochemical cell includes a counter electrode, and an electrocatalyst. The electrocatalyst includes a copper foam substrate and a nanocomposite. The nanocomposite includes iron oxide, cobalt oxide, and nickel oxide. Furthermore, particles of the nanocomposite are distributed on a surface of the copper foam substrate and the particles of the nanocomposite have a spherical shape with an average diameter of less than 500 nanometers (nm).
C25B 11/077 - Electrodes formed of electrocatalysts on a substrate or carrier characterised by the electrocatalysts material consisting of a single catalytic element or catalytic compound the compound being a non-noble metal oxide
A microchannel compact heat exchanging system is provided. The system includes a ribbed microchannel including a plurality of radial ribs and fins. A ratio between a thickness of each radial rib and a radius of the ribbed microchannel is within a first predefined range. A water-based nanofluid in the ribbed microchannel is prepared with polyethylene glycol (PEG) polymer, calcium chloride salt, and a graphene oxide carbon-based material. The system includes two plenums connected to the ribbed microchannel.
F28F 1/26 - Tubular elements or assemblies thereof with means for increasing heat-transfer area, e.g. with fins, with projections, with recesses the means being only outside the tubular element and extending transversely the means being integral with the element
B01J 19/00 - Chemical, physical or physico-chemical processes in generalTheir relevant apparatus
C09K 5/20 - Antifreeze additives therefor, e.g. for radiator liquids
F28F 23/00 - Features relating to the use of intermediate heat-exchange materials, e.g. selection of compositions
12.
System and methods for multi-robotic multi-product U-shaped disassembly line
A multi-robotic U-shaped disassembly line, a method for disassembling components on the multi-robotic U-shaped disassembly line, and a non-transitory computer readable medium that cause one or more processors to perform the method for disassembling components on the multi-robotic U-shaped disassembly line are provided. The multi-robotic U-shaped disassembly line uses multiple robots, assigned to multiple workstations to perform disassembly tasks without precedence and conflict relationships, so that different types of end-of-life products can be disassembled. A mathematical model is established to maximize the disassembly profit and minimize the smoothness index for the multi-robotic U-shaped disassembly line. An Improved Multi-objective Discrete Brainstorming Optimization (IMDBO) algorithm is utilized to identify improvements for the multi-robotic U-shaped disassembly line.
Compounds and methods for preventing and/or treating one or more symptoms of sickle cell diseases (SCD) by administering at least one of the compounds are provided. The compounds are chemically modified to increase bioavailability and activity, e.g., so that the compounds prevent adhesion and sickling of red blood cells (RBCs).
A61K 31/437 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
A61K 31/7048 - Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin
A gas hydrate desalination system that includes a reactor with a detachable water jacket and thermocouples. The reactor has a detachable lid having a liquid inlet, a gas inlet, sapphire glass lenses, and lid cameras. An exit concentrate channel is provided at a bottom of the reactor. A mixing unit of the system includes a liquid storage tank connected to the reactor through the liquid inlet, and a gas feed cylinder connected the reactor through the gas inlet. A resolving unit of the system includes a sieve filter column for filtering brine from gas hydrate. The sieve filter column is connected to the exit concentrate channel and a first fraction column, which is connected to a brine column. The channel is further connected to a second fraction column, which is connected to the brine column for separating freshwater from the gas hydrate.
A buccal tablet formulation has a polyvinylpyrrolidone K-90 as a solid dispersion polymer, a hydroxypropyl methylcellulose as a mucoadhesive polymer, a sodium deoxycholate as mucopenetration enhancer, a porous silicon dioxide (e.g., FujiSil), mannitol, and avanafil. The ratio of PVP K-90 to AVA is approximately 2:1 (e.g., 2.3:1 to 1.7:1) in the tablet. Methods of making the buccal tablet with enhanced bioavailability and prolonged duration and methods of using the formulation for the treatment of erectile dysfunction are also provided.
The present disclosure relates to methods for treating cancer/inhibiting tumor growth in a patient in need thereof comprising administering to the patient an effective amount of Glatiramer acetate (GA) and an effective amount of an immune checkpoint inhibitor.
A nanoemulsion, and a method of preparing the nanoemulsion is disclosed. The nanoemulsion includes sodium hypochlorite (NaOCl), chlorhexidine (CHX), and a self-nanoemulsifying delivery system (SNEDS) which further includes at least one oil, at least one surfactant, and at least one co-surfactant, wherein no parachloroaniline is present in the nanoemulsion after 1 hour at room temperature.
A01N 55/02 - Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur containing metal atoms
C07C 209/60 - Preparation of compounds containing amino groups bound to a carbon skeleton by condensation or addition reactions, e.g. Mannich reaction, addition of ammonia or amines to alkenes or to alkynes or addition of compounds containing an active hydrogen atom to Schiff's bases, quinone imines, or aziranes
20.
NANOPARTICLES INCLUDING A GLATIRAMOID USEFUL IN POLYNUCLEOTIDE DELIVERY
The present technology is directed to composition that may be formulated for parenteral administration, where the composition includes a plurality of nanoparticles and optionally a pharmaceutically acceptable carrier. Each nanoparticle of the plurality includes a glatiramoid and one or more of a polyinosine-polycytidylic acid (Poly(I:C)), a plasmid DNA (pDNA), a CpG oligodeoxynucleotide (CpG ODN), or a combination of any two or more thereof.
A61K 47/62 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
A61K 47/69 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
Nigella sativa oil extract. This oily composition is prepared and used as a treatment for addiction withdrawal symptoms by regulating dopamine and serotonin unbalance in a subject in need thereof. The prepared formulation alleviated the addiction effect of cocaine after daily single dosing of addiction-induced mice.
3 and X is a C1 to C20 hydrocarbon which is optionally substituted. The copper (II) complexes bind to an inactivate proteins that are necessary for the virus to successfully establish an infection and reproduce.
An organic resistor is provided. The organic resistor includes a rubber substrate and a conducting film disposed over the rubber substrate. The conducting film includes a composite of carbon nanotubes and a nickel phthalocyanine complex dispersed in one or more edible oil(s). The present disclosure also relates to a method of making the organic resistor using rubbing-in technology. The organic resistor of the present invention is environmentally friendly and ecologically clean.
H01C 7/18 - Non-adjustable resistors formed as one or more layers or coatingsNon-adjustable resistors made from powdered conducting material or powdered semi-conducting material with or without insulating material comprising a plurality of layers stacked between terminals
H01C 17/065 - Apparatus or processes specially adapted for manufacturing resistors adapted for coating resistive material on a base by thick-film techniques, e.g. serigraphy
B32B 17/06 - Layered products essentially comprising sheet glass, or fibres of glass, slag or the like comprising glass as the main or only constituent of a layer, next to another layer of a specific substance
B82Y 30/00 - Nanotechnology for materials or surface science, e.g. nanocomposites
B82Y 40/00 - Manufacture or treatment of nanostructures
24.
Modified nanoclay for heavy metal and salt removal from water
An 8-hydroxyquinoline modified halloysite nanoclay (8-HQHNC) is provided. The 8-HQHNC is used in a method of removing heavy metals and/or salt from a solution which includes steps of contacting the solution with 8-HQHNC under conditions suitable for the adsorption of the heavy metals and/or salt to the 8-HQHNC and recovering the 8-HQHNC from the solution.
B01J 20/22 - Solid sorbent compositions or filter aid compositionsSorbents for chromatographyProcesses for preparing, regenerating or reactivating thereof comprising organic material
B01J 20/12 - Naturally occurring clays or bleaching earth
C02F 1/28 - Treatment of water, waste water, or sewage by sorption
C02F 101/20 - Heavy metals or heavy metal compounds
25.
Synchronverter power control during unbalanced grid conditions
t, and regulate the current measurement vector i to eliminate power oscillations and current harmonics in the synchronverter during unbalanced grid conditions.
A gamma radiography system includes a gamma source holder, a shaft handle attached to the source holder, a source container that surrounds the source holder, a source container cover attached to the source container to receive and slidingly support the shaft handle, a shielded housing that detachably receives the source container, and an extension connected to the shielded housing, such that an opening of the extension covers a beam aperture of the shielded housing. The shaft handle is configured to move the gamma source holder between a non-deployed position, in which the gamma source holder is surrounded by the source container, to a deployed position, in which the gamma source holder extends from the source container into the shielded housing.
G21G 4/06 - Radioactive sources other than neutron sources characterised by constructional features
G01N 23/10 - Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups , or by transmitting the radiation through the material and measuring the absorption the material being confined in a container, e.g. in luggage X-ray scanners
G21F 5/015 - Transportable or portable shielded containers for storing radioactive sources, e.g. source carriers for irradiation unitsRadioisotope containers
2) and carbon monoxide (CO). The bimetallic supported catalyst includes 8 to 16 weight percent (wt. %) nickel and 2 to 14 wt. % copper, each based on a total weight of bimetallic supported catalyst.
C01B 3/40 - Production of hydrogen or of gaseous mixtures containing hydrogen by reaction of gaseous or liquid organic compounds with gasifying agents, e.g. water, carbon dioxide, air by reaction of hydrocarbons with gasifying agents using catalysts characterised by the catalyst
B01J 37/02 - Impregnation, coating or precipitation
A smart knee brace including a knee brace, multiple thigh bands, multiple shin bands, and multiple brace straps removably attached to one another and multiple motion actuators and sensors. Each motion actuator is connected to one brace strap and each sensor is connected to one motion actuator to measure an orientation of corresponding brace strap and generate a motion signal. A computing device receives the motion signals from the sensors; measures a current range of motion of the thigh, the shin, and the knee, and, based on the received motion signals, and generates drive signals based on the measured current range of motion. A native smart knee brace computer application on a smart phone of the user is operatively connected to the computing device and a cloud application server provide higher level analysis of the motions of the smart knee brace.
A61F 5/01 - Orthopaedic devices, e.g. long-term immobilising or pressure directing devices for treating broken or deformed bones such as splints, casts or braces
A61H 1/02 - Stretching or bending apparatus for exercising
B25J 13/08 - Controls for manipulators by means of sensing devices, e.g. viewing or touching devices
Systems and methods include a reduced computation, computer-based management of point-of-care (POC) on-site ultrasound (ULS) imaging resources. At a digital computation resource of a POC site, a ULS tissue reflection sample data is received from a hand-held ULS scanning device. A digital computation resource of the POC site, applies a reduced computation tissue ULS reflection speckle noise (SN) physics model—blurring noise (BN) physics model based deep learning (DL) trained convolutional neural network (CNN) denoising process to the ULS tissue reflection sample data outputting an estimated denoised ULS tissue reflection image data. A visual rendering of the estimated denoised ULS tissue reflection image data is displayed on a display resource of the POC site.
A buccal tablet formulation has a polyvinylpyrrolidone K-90 as a solid dispersion polymer, a hydroxypropyl methylcellulose as a mucoadhesive polymer, a sodium deoxycholate as mucopenetration enhancer, a porous silicon dioxide (e.g., FujiSil), mannitol, and avanafil. The ratio of PVP K-90 to AVA is approximately 2:1 (e.g., 2.3:1 to 1.7:1) in the tablet. Methods of making the buccal tablet with enhanced bioavailability and prolonged duration and methods of using the formulation for the treatment of erectile dysfunction are also provided.
Examples include receiving and storing samples of target frequency bands filtered from EEG measurement of a subject's brain waves in an NFB training session. In an example, upon storing a time window of the samples, unsupervised adaptive adjusting an NFB reward threshold is automatic. The adjusting includes, in examples, determining neuromarker values in the time window, which indicate peak values of the target frequency bands over the time window. The adjusting computes the mean value of the neuromarker values and, utilizing same, automatically proceeds to unsupervised computing an adaptive adjusted reward threshold. The unsupervised computing, in examples, includes a multiplication product of a reward threshold adjustment factor, a training protocol value, and the computed mean value of the neuromarker values. Examples proceed to communicating the adaptive adjusted reward threshold to a controller for threshold based feedback reward to the NBF subject.
Provided is a method for synthesizing cobalt-incorporated carbon nanotubes (Co/MWCNTs). The method includes a step of mixing cobalt acetate, cobalt nitrate, cobalt chloride, or cobalt sulfate with multi-wall carbon nanotubes in a solvent. A method for generating hydrogen by using the Co/MWCNTs as a catalyst component is also provided herein.
C01B 3/06 - Production of hydrogen or of gaseous mixtures containing hydrogen by reaction of inorganic compounds containing electro-positively bound hydrogen, e.g. water, acids, bases, ammonia, with inorganic reducing agents
B01J 23/80 - Catalysts comprising metals or metal oxides or hydroxides, not provided for in group of the iron group metals or copper combined with metals, oxides or hydroxides provided for in groups with zinc, cadmium or mercury
C25B 11/077 - Electrodes formed of electrocatalysts on a substrate or carrier characterised by the electrocatalysts material consisting of a single catalytic element or catalytic compound the compound being a non-noble metal oxide
A magnetic guide device for intraoral radiography is described. The magnetic guide device comprises a metal rod having a first rod end and a second rod end. The magnetic guide device further comprises a ring slidably attached to the metal rod between the first rod end and the second rod end. The magnetic guide device further comprises a plurality of magnetic attachments. The magnetic guide device further comprises a rectangular collimator attached to the ring by the magnetic attachments. The magnetic guide device further comprises a CMOS sensor. The magnetic guide device further comprises a metal fork having a fork handle slidably attached to the metal rod between the CMOS sensor and the first rod end. The metal fork is configured to hold the CMOS sensor during an intraoral radiography procedure.
A dental filling material comprising bioactive borate glass particles, wherein the particles are at a concentration of 40-60 wt %, a co-monomer resin blend, a photoinitiator, and a co-initiator is provided. Method for applying the dental filling material to a tooth structure are also provided. The temporary filling material re-mineralizes the tooth structure and is removed after 1-7 days for the placement of a permanent filling material.
A method for removing silica from an aqueous solution is provided. The method includes steps of flowing the aqueous solution into an electro-Fenton reactor, wherein the reactor comprises one or more electrodes in a bipolar arrangement positioned between a monopolar iron anode and a monopolar cathode; applying an electric current to the aqueous solution such that silica aggregates form on ferric hydroxide; and removing the silica aggregates from the aqueous solution.
Flexible and shockproof electrochemical cells for simultaneously detecting infrared and ultraviolet irradiation are provided. The electrochemical sensors comprise a flexible electrolyte comprising an orange dye suspended in a gel.
A distributed airborne acoustic anti-drone intelligence system (DAAADS) which senses an unmanned aerial vehicle (UAV) approaching a protected site, predicts trajectories of the UAV which intersect the protected site and identifies the type of the UAV. When at least one of the trajectories intersect the protected site, an alarm and predicted trajectories are transmitted to an air defense unit, which neutralizes the UAV. Debris generated by the neutralization is tracked and trajectories of the debris are predicted. When a trajectory of the debris is predicted to intersect with the protected site, an alert is transmitted to the protected site.
A surface modified electrode and a method of preparing the surface modified electrode are provided. The surface modified electrode includes a glassy carbon electrode and a coating of a compound of formula I disposed on the glassy carbon electrode. The present disclosure also relates to a method of preparing the surface modified electrode. The method includes depositing a slurry of the compound of Formula I on the glassy carbon electrode to form a film and coating a polymer matrix on the film to obtain the surface modified electrode. The present disclosure also relates to a method of preparing the compound of Formula I. The method includes condensing 4-bromobenzaldehyde (4-BBD) and 4-methyl-benzenesulphonylhydrazine (4-MBSH), to obtain a first mixture and precipitating the first mixture to obtain the compound of Formula I. The surface modified electrode is used in an electrochemical sensor for the detection of metal ions.
C07C 311/49 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups having nitrogen atoms of sulfonamide groups further bound to another hetero atom to nitrogen atoms
C07C 303/40 - Preparation of esters or amides of sulfuric acidsPreparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
A nano-pharmaceutical formulation, comprising zein nanoparticles, icariin (ICA) or a pharmaceutically acceptable salt thereof encapsulated within the zein nanoparticles, at least one solubilizer, wherein the at least one solubilizer comprises D-a-Tocopherol polyethylene glycol 1000 succinate (TPGS), and one or more pharmaceutical penetration enhancers is provided. Methods of enhancing libido by administering a composition as described herein is also provided.
3.CNT NCs). A polymer matrix is configured to bind the glassy carbon electrode with the nanomaterial. A method of preparing the surface modified electrode is also disclosed. The surface modified electrode can be implemented in a biosensor for detecting a biological molecule, like choline.
Methods, systems and wearable devices for real-time mental stress assessment are provided. The methods and systems employ deep learning using a Gated Recurrent Unit (GRU) gating mechanism in a recurrent neural network with a sliding window approach applied to raw EEG data.
G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
44.
Injectable drug delivery implant composition and method of use thereof
Provided are an injectable and implantable drug delivery composition and a method for using such composition to release active ingredients and/or pharmaceutical agents to a site of action. The composition includes a gellan-gum crosslinked with L-cysteine and at least one pharmaceutical active agent in a biocompatible solvent.
A61K 47/36 - PolysaccharidesDerivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
A61K 47/20 - Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
A61P 25/00 - Drugs for disorders of the nervous system
A61K 9/00 - Medicinal preparations characterised by special physical form
A61P 21/00 - Drugs for disorders of the muscular or neuromuscular system
45.
Flexible infrared irradiation and temperature sensors
A flexible infrared irradiation and temperature sensor is provided. The sensor includes a substantially cubic deformable rubber substrate and a conductive layer embedded in the rubber substrate, wherein the conductive layer comprises a middle portion comprising a composite film of carbon nanotubes (CNTs) and nickel phthalocyanine (NiPc); and one or more exterior portions comprising carbon nanotubes, wherein the one or more exterior portions do not include NiPc.
Self-nanoemulsifying drug delivery system (SNEDDS) composition are provided. The compositions include at least one chemotherapeutic compound or a pharmaceutically acceptable salt thereof or mixture thereof, at least one biocompatible surfactant, wherein the at least one biocompatible surfactant includes surfactin, and at least one co-surfactant. Methods of enhancing the bioavailability of the chemotherapeutic compound and for treating cancer are also provided.
An apparatus, and a system for manufacturing a bioplastic material from a blend solution of gum arabica (GA) and polyvinyl alcohol (PVA) is provided. The apparatus includes a panel having a first end, a second end distal to the first end, and a plurality of walls extending from a periphery of the panel, the panel configured to accommodate the blend solution. The apparatus further includes a plurality of support members coupled to the first end and the second end of the panel and configured to adjust a slope angle of the panel; and one or more vibration generating units coupled to the plurality of support members and configured to vibrate the panel when the blend solution flows from the first end to the second end of the panel. A method of preparing the bioplastic material is also disclosed.
B29C 41/00 - Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped articleApparatus therefor
B29C 41/02 - Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped articleApparatus therefor for making articles of definite length, i.e. discrete articles
B29C 41/50 - Shaping under special conditions, e.g. vacuum
Methods for treating coronavirus infection, such as an infection caused by SARS-CoV-2, in a subject in need thereof include administering to the subject a therapeutically effective amount of a composition comprising an isolated polypeptide targeting the spike protein and the transmembrane region of the coronavirus envelope protein. Compositions include isolated polypeptides complementary to residues 30-38 of the envelope protein transmembrane region.
The present disclosure provides tetrahydroquinoline derivatives of Formula (I)
4 each, independently, are hydrogen, or lower alkyl groups; and R5 and R6 are optionally substituted aryl groups. The present disclosure also provides a method for making the compound of Formula (I).
Thioctamer, a nanoconjugate of glatiramer acetate (GA) and thioctic acid (TA), e.g. in the form of nanospheres, is provided as are compositions comprising thioctamer and methods of using the same for wound healing. Application of thioctamer to a wound accelerates wound healing, compared to control wounds that are not treated with the copolymer.
A61K 47/54 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
A61P 17/02 - Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
Azadirachta indica leaf extracts are provided. The sulfated carboxymethyl cellulose is made using an improved, environmentally friendly technique. Methods of using the biocomposites as anticoagulants are also provided.
A61K 36/58 - Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
A61K 47/52 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
A61K 47/61 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
52.
Pyridine derivatives for the treatment of hyperproliferative diseases
Methods of inducing apoptosis of cancer cells by contacting the cancer cells with a pyridine derivative are provided. Methods of treating a subject suffering from a hyperproliferative disease or complications thereof comprising the step of administering a therapeutically effective amount of a composition to the subject, wherein the composition comprises pyridine derivatives are provided.
C07D 519/00 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or
C07D 409/12 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Therapeutic compounds containing an arylacetamide core pending N-benzyl group. Also described are pharmaceutical compositions incorporating the therapeutic compounds and a method for inhibiting AMP-activated kinase (AMPK) and their use thereof for treating breast and pancreatic cancer with the specified compounds.
C07D 213/75 - Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
C07D 295/088 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
C07C 235/56 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
C07D 307/68 - Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
An antimicrobial air treatment device and a method of its construction. The antimicrobial air treatment device comprises an antimicrobial metal nanoparticle mesh comprising a steel support mesh and a layer of copper nanoparticles disposed on the steel support mesh. The antimicrobial air treatment device may be in the form of a facemask or a component of a moving air filtration system such as an HVAC system, an automobile cabin air filtration system, and an air purifier. The antimicrobial air treatment device may contain one or more filtration layers of filtration medium. The method of constructing the antimicrobial air treatment device involves the preparation of the antimicrobial metal nanoparticle mesh by an electrodeposition technique.
Arene-immobilized Ru(II)TsDPEN Noyori-Ikariya catalysts anchored to silica through the coordinated η6-arene are provided. The catalysts efficiently catalyze many reactions, including the asymmetric transfer hydrogenation of ketones to alcohols.
C07F 15/00 - Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
C07C 29/143 - Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen-containing functional group of C=O containing groups, e.g. —COOH of ketones
B01J 31/18 - Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony
A prostate grasping morcellator device and a method of morcellating prostate tissue are described. The prostate grasping morcellator device includes a handpiece portion including a motor which rotates an internal sheath in an external sheath of a rod. The rod is connected to a second end of the handpiece portion. The prostate grasping morcellator device includes one or more retractable grasping nails connected to an end of the rod. The end is distal to the second end of the handpiece portion. The prostate grasping morcellator device includes a control button to control movement of the retractable grasping nails. The control button is mounted adjacent to the second end of the handpiece portion. The prostate grasping morcellator device includes one or more blades, rotated by the motor to morcellate tissue.
A61B 90/00 - Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups , e.g. for luxation treatment or for protecting wound edges
G16H 40/63 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
G16H 20/40 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
58.
Methods for using 5-HMF analogs with increased solubility to inhibit or reverse RBC sickling
2 affinity of HbS to an equilibrium point within 30 to 90 minutes. The compounds have a desired level of safety as well as a short half-life, both of which are compatible with acute usage. Thus, the methods of treatment rapidly achieve therapeutic steady-state drug levels, making it possible to deliver a treatment in critical emergency care situations to prevent, reverse and otherwise treat acute sickling or anemia.
A61K 31/5377 - 1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
A61K 31/341 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
A61K 31/4155 - 1,2-Diazoles not condensed and containing further heterocyclic rings
A61K 31/496 - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
A61K 31/351 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
A61K 31/4525 - Non-condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
Provided are synthesis methods of polymerizing aniline or derivatives thereof. The production of polyaniline or polyaniline derivatives is controlled by the type of oxidant added in the reaction medium. The methods include the step of using a safe and environmentally friendly carbomethyl cellulose (CMC) or modified CMC as an oxidant in the polymerization reaction to produce polyaniline or aniline derivatives. Synthesis methods of producing O-CMC and O-CMC-S oxidants are also provided herein.
A synthetic DNA vaccine against SARS-CoV-2 infection comprises a codon-optimized coding sequence for optimal mammalian expression of a pSARS2 spike glycoprotein (pSARS2-S). The signal peptide may be replaced with the signal peptide from the human IgG2 heavy chain. Systemic S1-specific IgG antibodies and neutralizing antibodies (nAbs) were significantly induced in mice at 2 weeks-post three injections with 100 μg of the pSARS2-S vaccine via intramuscular (IM) needle injection. IM immunization induced Th1-skewed and long-lasting IgG response in BALB/c mice. Immunogenicity and induction of nAbs were enhanced with a needle-free delivery system, wherein two doses were sufficient to elicit significant levels of systemic S1-specific IgG antibodies and nAbs via IM or intradermal immunization.
2·s·Pa). A method to prepare the packaging film is also disclosed. The packaging films of the present disclosure prevent or inhibit the growth of gram-positive bacteria and gram-negative bacteria, particularly on food surfaces.
B65D 81/24 - Adaptations for preventing deterioration or decay of contentsApplications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants
B29K 105/00 - Condition, form or state of moulded material
B29C 48/00 - Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired formApparatus therefor
B29C 48/08 - Flat, e.g. panels flexible, e.g. films
B29K 67/00 - Use of polyesters as moulding material
A method of obtaining rayon fibers from cellulose waste is provided. The method includes extracting alpha-cellulose from cellulose waste, dissolving the alpha-cellulose in a cuoxam solution, obtained by reacting gaseous ammonia with an aqueous solution of copper hydroxide, to obtain a chemically modified cellulose. The chemically modified cellulose was extruded in an acid bath to obtain a precipitate. The precipitate was further neutralized to obtain the rayon fibers.
D01F 2/04 - Monocomponent artificial filaments or the like of cellulose or cellulose derivativesManufacture thereof from solutions of cellulose in acids, bases, or salts from cuprammonium solutions
D21C 9/08 - Removal of fats, resins, pitch, or waxes
D21B 1/32 - Defibrating by other means of waste paper
D01F 2/08 - Composition of the spinning solution or the bath
D21C 3/04 - Pulping cellulose-containing materials with acids, acid salts, or acid anhydrides
4 by hydrolysis or alcoholysis are provided. The catalysts comprise hydrogel beads formed from alginate and starch. The hydrogel beads optionally comprise metal nanoparticles on their surfaces, and the hydrogen generation reactions are optionally conducted in the presence of one or more surfactants.
Salmonella typhimurium. Treatment with the NK-lysin peptides repressed β-lactam-resistance genes (CTX-M-1, CTX-M-8 and CTX-M-9) in bacterial species tested and thus can be used to augment treatment with β-lactams and increase bacterial sensitivity to this important class of antibiotics.
A method of determining shear strength of soil using a fall cone apparatus is provided. The method includes generating a first plot having graph lines defined for penetration depth values ranging from 4 to 20 mm on a first logarithmic paper, deducing a first mathematical model based on the first plot, and generating a second plot having the graph lines extended for a predefined penetration depth range based on the first mathematical model. The method further includes generating a third plot having graph lines corresponding to the extended penetration depth values defined for the W/A ratio values ranging from 0.17 to 13.3 on a second logarithmic paper, deducing a second mathematical model based on the third plot, generating a fourth plot having the graph lines extended for a predefined W/A ratio range based on the second mathematical model, and determining shear strength based on the fourth plot.
G01N 3/303 - Investigating strength properties of solid materials by application of mechanical stress by applying a single impulsive force generated only by free-falling weight
66.
Compositions and methods for the treatment of coronavirus infection
A61K 36/28 - Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
A61K 31/343 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
67.
Secure encryption and decryption method and system
Memristor based chaotic oscillators exhibit complex dynamics. They are often chosen for secure communication owing to their interesting feature. In chaos-based secure communication applications using the master-slave configuration, synchronization is a central issue. Most of the synchronization methods proposed in the literature are asymptotic. In practice, it is desirable that synchronization be established in a predefined time. This invention provides new developments in the design of high-gain observers with an unknown input dedicated for predefined-time synchronization of memristor based chaotic systems. The proposed predefined-time extended high gain observer is constructed on the basis of a time-dependent coordinates transformation based on modulating functions that annihilate the effect of initial conditions on the synchronization time. Both noise-free channel and noisy channel are considered. Simulations performed on a numerical example illustrated the efficiency of proposed approaches.
A membrane filter apparatus for splitting a feed into filtrate and retentate is provided. The apparatus comprises a body chamber, a feed inlet disposed on the body chamber, a retentate outlet located in the body chamber, a feed distribution tube connected to the feed inlet, and a filter assembly having a filter. The feed distribution tube has a length sufficient to cause the feed to enter the body chamber at a feed distance from the filter assembly of no greater than 50% of a total length of the body chamber. The feed flows across the filter in a direction parallel to a surface of the filter assembly. The filtrate passes through the filter assembly and the retentate flows through the body chamber in a direction antiparallel to the feed flow through the feed distribution tube and out through the retentate outlet.
A method of forming a vibration-damped aluminum article is provided. The method includes forming a groove in a surface of an aluminum substrate, the groove having a groove depth which is less than 50% of a thickness of the aluminum substrate. The method further includes placing metal oxide nanoparticles in the groove to form an unmixed composite. The method further includes friction stir processing the unmixed composite to form the vibration-damped aluminum article. The friction stir processing includes at least two passes over the unmixed composite. The vibration-damped aluminum article includes a surface nanocomposite portion and an aluminum alloy portion. The metal oxide nanoparticles are substantially free of metal carbides, metal borides, and carbon nanomaterials.
B23K 20/12 - Non-electric welding by applying impact or other pressure, with or without the application of heat, e.g. cladding or plating the heat being generated by frictionFriction welding
A method of making a composite laminate includes dequilling chicken feathers to form chicken feather fibers (CFFs). The CFFs and Ceiba Pentandra bark fibers (CPFs) are milled to form milled CFFs and milled CPFs so that the milled CFFs have a length of smaller than 200 microns and the milled CPFs have a length of smaller than 600 microns. The CFFs are treated with an amine compatibilizer to esterify carboxy groups present on keratin in the CFFs. A mixture of an epoxy resin, the milled CFFs, and the milled CPFs is solution cast to form an epoxy composite. A first carbon fabric layer and a second carbon fabric layer are placed on a front side and a backside, respectively, of the epoxy composite to form an epoxy laminate precursor. The epoxy laminate precursor is compression molded to cure the epoxy laminate precursor to form the composite laminate.
B29C 43/00 - Compression moulding, i.e. applying external pressure to flow the moulding materialApparatus therefor
B29C 70/02 - Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts comprising combinations of reinforcements and fillers incorporated in matrix material, forming one or more layers, with or without non-reinforced or non-filled layers
D01F 4/00 - Monocomponent artificial filaments or the like of proteinsManufacture thereof
D01C 1/02 - Treatment of vegetable material by chemical methods to obtain bast fibres
D01C 3/00 - Treatment of animal material, e.g. chemical scouring of wool
B29C 43/14 - Compression moulding, i.e. applying external pressure to flow the moulding materialApparatus therefor of articles of definite length, i.e. discrete articles in several steps
B29K 105/12 - Condition, form or state of moulded material containing reinforcements, fillers or inserts of short lengths, e.g. chopped filaments, staple fibres or bristles
A viscous fluid reaction apparatus is described. The viscous fluid reaction apparatus comprises a glass reaction vessel. The viscous fluid reaction apparatus further comprises a gas-tight inlet assembly and a gas-tight stirrer assembly. The gas-tight stirrer assembly comprises a stirrer opening adapter, a stirrer coupling comprising a stirrer shaft seal connected to the stirrer opening adapter, a stirrer shaft comprising one or more stirrer blades located at a blade end of the stirrer shaft, and a motor coupling connected to the stirrer shaft. The viscous fluid reaction apparatus further comprises a motor connected to the motor coupling. The stirrer shaft passes through the stirrer coupling and the stirrer opening adapter such that the stirrer blade(s) are disposed in the glass reaction vessel at a blade height and the stirrer shaft is configured to rotate without compromising a gas-tight seal formed by the stirrer shaft seal.
B01F 23/233 - Mixing gases with liquids by introducing gases into liquid media, e.g. for producing aerated liquids using driven stirrers with completely immersed stirring elements
72.
Crowd evacuation system based on real time perception, simulation, and warning
A method for real-time crowd management includes receiving LiDAR point cloud data from area of interest, forming a 3D static surface model of area of interest from LiDAR point cloud data, obtaining real-time CCTV camera images of area of interest, adding real-time CCTV camera images to 3D static surface model to generate real-time dynamic 3D model, identifying dynamic objects in the 3D model, generating a density map of an area of interest, adding density map to the 3D model, identifying which dynamic objects are people, replacing each person with animated character, displaying real-time dynamic 3D model, monitoring the 3D model in the area of interest for dangerous situations, simulating evacuation of area of interest by manipulating animated characters onto pathways leading away from area of interest, forming an evacuation strategy for crowd, and transmitting a notice of the dangerous situation and the evacuation strategy to an emergency authority.
G06Q 90/00 - Systems or methods specially adapted for administrative, commercial, financial, managerial or supervisory purposes, not involving significant data processing
G08B 21/02 - Alarms for ensuring the safety of persons
Heterophragma adenophyllum seem. The inhibitors are used to lower blood sugar levels and thus to treat diseases related to or characterized by high blood sugar, such as diabetes.
A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
C07C 46/10 - SeparationPurificationStabilisationUse of additives
C07D 311/94 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
C07D 311/78 - Ring systems having three or more relevant rings
C07C 67/58 - SeparationPurificationStabilisationUse of additives by liquid-liquid treatment
A61K 31/122 - Ketones having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K1, anthralin
A61K 31/216 - Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
74.
EAR SUCTIONING DEVICE AND METHOD OF PROVIDING SUCTION TO EAR CANAL
An ear suctioning device having a suction tube and a disposable hollow tip is provided. The suction tube has a distal segment and a proximal segment which are angled with respect to each other at about 130 to 170 degrees. The disposable hollow tip is reversibly connected to a distal end of the suction tube and fluidly connected to the suction tube. The disposable hollow tip comprises a safety flange which prevents the suction tube from contacting an ear or ear canal into which the ear suctioning device is inserted. A pressure-equalizing hole is disposed on the proximal segment of the suction tube and in fluid communication with an interior volume of the suction tube. A proximal end of the suction tube is attached to a vacuum or low pressure line.
A61M 1/00 - Suction or pumping devices for medical purposesDevices for carrying-off, for treatment of, or for carrying-over, body-liquidsDrainage systems
A removable cosmetic dental structure and a method of fabricating the removable cosmetic dental structure is provided. The removable cosmetic dental structure includes a removable veneer body, having a front side and a rear side, sized to cover at least a portion of a facial surface of a tooth structure. The front side of the removable veneer body is shaped to resemble a tooth surface and the rear side of the removable veneer body covers the facial surface of the tooth structure. The removable cosmetic dental structure further includes one or more magnetic layers integrated on the rear side of the removable veneer body. The magnetic layers are configured to hold the removable veneer body to the facial surface of the tooth structure.
A method for detecting MERS-CoV at high sensitivity and specificity using IgY antibodies that bind to MERS-CoV N protein, its fragments and domains. Isolated or purified IgY monospecific antibodies to MERS-CoV N protein.
A pulsed electromagnetic irradiation system for water treatment including raw water supply unit in fluid communication with a reaction vessel, a multimode cavity in which the reaction vessel is partially positioned. A magnetron generator is positioned adjacent the multimode cavity and is electromagnetically coupled with liquid within the reaction vessel. A stirring motor is positioned adjacent a bottom surface of multimode cavity and operatively coupled with the reaction vessel to stir the liquid within reaction vessel. A parabolic arm air cooled condenser is terminally connected to the reaction vessel to be in fluid communication with the reaction vessel. A gravity vacuum funnel, where the gravity vacuum funnel is in communication with a first air/water cooled condenser. The first air/water cooled condenser outputs fresh water to a fresh water storage unit.
A system, method, and non-transitory computer readable medium that detects trajectories of unmanned aerial vehicles (UAV) approaching a protected site is described. Airborne defense agents (ADAs) located at a fixed radius from the protected and equidistant from one another detect acoustic signals emitted by an approaching UAV. Circuitry included in each ADA use the detected acoustic signals to determine a direction and a distance of each UAV. A base station having a control center (BS-CC) located in the protected site communicates with the ADAs to aggregate direction and distance data from the ADAs. Using the aggregated direction and distance data, the BS-CC predicts routes towards the protected site of the approaching UAV and alerts the protected site of the predicted route of the approaching UAV.
A filament or printing material placed in a syringe for 3D printing comprising polymers, proteins, and/or functional particles and materials is provided. Methods of treating a bone defect in a subject in need thereof comprising using a handheld 3D printer to apply a filament or the printing material placed in a syringe to the bone defect of the subject are also provided. Methods of fixing or gluing natural or synthetic bone grafts using a handheld 3D printer to apply a filament or the printing material placed in a syringe over and around the defect or at the interface of a flap and the bone. Methods of printing a graft cage for retaining bone grafts and/or bone graft substitute in its desired location during healing for treatment of critical-sized segmental defects in long bones are provided.
2O and CuO. The method involves treating the copper mesh support with a plant extract to form a treated mesh and annealing the treated mesh at 210 to 500° C. The nanomaterial catalyst mesh is used in a method of photodegrading an organic pollutant, preferably a dye, involving hydrogen peroxide and visible light.
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (USA)
Inventor
Memic, Adnan
Abudula, Tuerdimaimaiti
Tamayol, Ali
Mostafavi, Azadeh
Russell, Carina
Williams, Tyrell
Salah, Numan Abdullah
Alshahrie, Ahmed Salem
Melaibari, Ammar Abdulghani
Memic, Asija
Abdelwahab, Mohammed Shaaban
Narbat, Mehdi Kazemzadeh
Abstract
A filament or printing material placed in a syringe for 3D printing comprising polymers, proteins, and/or functional particles and materials is provided. Methods of treating a bone defect in a subject in need thereof comprising using a handheld 3D printer to apply a filament or the printing material placed in a syringe to the bone defect of the subject are also provided. Methods of fixing or gluing natural or synthetic bone grafts using a handheld 3D printer to apply a filament or the printing material placed in a syringe over and around the defect or at the interface of a flap and the bone. Methods of printing a graft cage for retaining bone grafts and/or bone graft substitute in its desired location during healing for treatment of critical-sized segmental defects in long bones are provided.
A61L 27/46 - Composite materials, i.e. layered or containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers
B29C 64/118 - Processes of additive manufacturing using only liquids or viscous materials, e.g. depositing a continuous bead of viscous material using filamentary material being melted, e.g. fused deposition modelling [FDM]
B33Y 80/00 - Products made by additive manufacturing
B33Y 70/00 - Materials specially adapted for additive manufacturing
A method of treating a landfill leachate containing ammoniacal nitrogen and phosphate by mixing with seawater to precipitate magnesium ammonium phosphate (MAP) also known as struvite. Effects of pH, temperature, stirring speed, and magnesium to ammonia molar ratio on leachate properties such as COD, ammoniacal nitrogen, phosphate content, color, turbidity, amount of magnesium, iron and zinc are disclosed. The method provides high removal efficiency for removal of ammoniacal nitrogen, phosphate, COD, color and turbidity. The method provides a cost-effective system for treatment of landfill leachate and recovery of MAP.
A system and a method for measuring drilling damage in fiber reinforced plastic (FRP) composites is described. Multiple holes are drilled in the FRP composite using a drill having nominal diameter, and the FRP composite is separated into multiple drilled blocks. Each block, covered with the black substrate, is scanned on a scanner to generate a scanned image depicting a hole region, a background, and delamination damage peaks. For each scanned image, a maximum delamination damage peak and a maximum diameter of a first circle concentric with the drilled hole and passing through tip of the maximum delamination peak, are measured. Further, a delamination size and a delamination factor are calculated based on the maximum diameter of the first circle and the nominal diameter of the drill.
G01N 23/2251 - Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups , or by measuring secondary emission from the material using electron or ion microprobes using incident electron beams, e.g. scanning electron microscopy [SEM]
G01N 3/06 - Special adaptations of indicating or recording means
B23B 49/00 - Measuring or gauging equipment on boring machines for positioning or guiding the drillDevices for indicating failure of drills during boringCentring devices for holes to be bored
C23C 14/20 - Metallic material, boron or silicon on organic substrates
C23C 14/02 - Pretreatment of the material to be coated
A method for correct operation of the current-angle-based phase-selection method (PSM) is based on a proper dual current controller (DCC) for inverter interfaced sources during unbalanced fault conditions. The fault type is determined in the inverter using voltage-angle-based PSM. Accordingly, fault-type zones' bisectors of the current-angle-based are determined. Consequently, an initial negative-sequence current angle reference is determined to force the relative angle between the negative- and zero-sequence currents in the center of its correct fault-type zone. The initial positive-sequence current angle is determined according to reactive current requirements by grid codes. These initial angles are updated for accurate operation of the PSM and appropriate reactive current injection. Negative- and positive-sequence current references are determined in the stationary frame to comply with the reference angles and inverter's thermal limits. These references are regulated by a proportional-resonance controller.
H02J 3/00 - Circuit arrangements for ac mains or ac distribution networks
G05B 19/042 - Programme control other than numerical control, i.e. in sequence controllers or logic controllers using digital processors
H02J 13/00 - Circuit arrangements for providing remote indication of network conditions, e.g. an instantaneous record of the open or closed condition of each circuitbreaker in the networkCircuit arrangements for providing remote control of switching means in a power distribution network, e.g. switching in and out of current consumers by using a pulse code signal carried by the network
H02J 3/38 - Arrangements for parallelly feeding a single network by two or more generators, converters or transformers
85.
Convolutional neural networks based computationally efficient method for equalization in FBMC-OQAM system
A filter bank multi-carrier (FBMC)-offset quadrature amplitude modulation (OQAM) system is disclosed. The FBMC-OQAM system includes a processing circuitry which is configured to receive a signal over a transmission medium, equalize the signal by a convolution neural network (CNN) equalizer, wherein the CNN equalizer is configured to estimate the received signal without performing channel estimation, and output the estimated signal as a bit stream.
An oil-in-water nanoemulsion is provided. The nanoemulsion contains 8-12% w/v essential oil, 1-5% w/v polysorbate 80 surfactant, 2-6% w/v glyceryl citrate/lactate/linoleate/oleate co-surfactant, and 1-5% w/v glycerol monocaprylate, type I, wherein a ratio of the surfactant and co-surfactant to essential oil is from 1:1.1 to 1:1.6. Methods of preparing the nanoemulsion and for the transdermal delivery of the nanoemulsion are also provided.
A computing device, method, and a non-transitory computer readable medium for articulation training for hearing impaired persons is disclosed. The computing device comprises a database including stored mel-frequency cepstral representations of audio recordings associated with text and/or images related to the audio recordings, a microphone configured to receive audible inputs and a display. The computing device is operatively connected to the database, the microphone and the display. The computing device includes circuitry and program instructions stored therein which when executed by one or more processors, cause the system to receive an audible input from the microphone, convert the audible input to a mel-frequency cepstral representation, search the database for a match of the mel-frequency cepstral representation to a stored mel-frequency cepstral representation and display the text and/or images related to the stored mel-frequency cepstral representation when the match is found.
G09B 21/00 - Teaching, or communicating with, the blind, deaf or mute
G10L 25/24 - Speech or voice analysis techniques not restricted to a single one of groups characterised by the type of extracted parameters the extracted parameters being the cepstrum
G10L 21/10 - Transforming into visible information
A distributed acoustic anti-unmanned boat intelligence system (DAAUBS) for detecting unmanned boats (UB) approaching protected sites includes a plurality of airborne defense agents (ADAs) and a base station. Each ADA is equipped with air balloons, tethers, buoys, a directional microphone array, a first computing device, and a transceiver. The first computing device causes at least processor to determine information regarding each approaching UB. The base station includes a control center configured with a wideband communications link configured to communicate with the transceiver of each ADA. The DAAUBS control center includes a second computing device performing an intelligence method. The second processor receives and aggregates the data of each approaching UB and performs adaptive noise cancellation to remove environmental background noise. The second processor uses a deep learning classifier to classify at least one of a type and size of the UB.
B63B 79/10 - Monitoring properties or operating parameters of vessels in operation using sensors, e.g. pressure sensors, strain gauges or accelerometers
G01S 7/52 - Details of systems according to groups , , of systems according to group
G01S 15/46 - Indirect determination of position data
G01S 15/58 - Velocity or trajectory determination systemsSense-of-movement determination systems
An artificial intelligence reactive power control system for low voltage ride-through in a grid connected distributed generation network includes a grid, a circuit breaker, a distributed generation circuit including 3-phase terminals, and a voltage and current measurement unit connected to the 3-phase terminals and configured to generate a set of measured variables. An intelligent low voltage ride-through detector receives the set of measured variables and identifies a low voltage ride-through status of the utility grid. An intelligent reactive power controller receives a low voltage ride-through status signal from the intelligent low voltage ride-through detector and controls a low voltage ride-through during a grid voltage sag and a voltage reduction by transmitting one or more of an active power reference and a reactive power reference value to the distributed generation circuit based on the low voltage ride-through status signal.
H02J 3/16 - Circuit arrangements for ac mains or ac distribution networks for adjusting voltage in ac networks by changing a characteristic of the network load by adjustment of reactive power
H02J 3/06 - Controlling transfer of power between connected networksControlling sharing of load between connected networks
H02J 13/00 - Circuit arrangements for providing remote indication of network conditions, e.g. an instantaneous record of the open or closed condition of each circuitbreaker in the networkCircuit arrangements for providing remote control of switching means in a power distribution network, e.g. switching in and out of current consumers by using a pulse code signal carried by the network
G05B 13/02 - Adaptive control systems, i.e. systems automatically adjusting themselves to have a performance which is optimum according to some preassigned criterion electric
H02J 3/38 - Arrangements for parallelly feeding a single network by two or more generators, converters or transformers
A system for controlling smartphones of drivers of moving automobiles including a plurality of smartphones, each smartphone including a GPS unit to record speed and location of smartphone, a driver control application to control access to phone services and social media applications, a low frequency receiver to receive low frequency radio frequency identification, an LF RFID, signal from key fob located within moving automobile, and a computing unit to measure a received signal strength indicator, RSSI, of LF RFID signal, a transmitter to transmit the speed, location, LF RFID signal, and RSSI to a centralized monitor. The centralized monitor includes a computing circuitry to receive the speed, location, LF RFID signal, and RSSI of each smartphone, generate clusters of speeds and locations of smartphones, analyze clusters to determine smartphones located within a particular moving automobile, determine smartphone of driver, and transmit a control signal to the smartphone of the driver.
H04M 1/72463 - User interfaces specially adapted for cordless or mobile telephones with means for adapting the functionality of the device according to specific conditions to restrict the functionality of the device
H04W 8/22 - Processing or transfer of terminal data, e.g. status or physical capabilities
94.
Method of optimizing multi-cell association in downlink multi-user, multiple-input, multiple-output (MU-MIMO) systems via statistical beamforming
th cell. Based on the determination, the user terminals are connected to their respective cells and the weight parameters are applied toward a beamforming configuration for the plurality of base stations. A device is also provided having processing circuitry configured to perform the method.
H04B 7/08 - Diversity systemsMulti-antenna systems, i.e. transmission or reception using multiple antennas using two or more spaced independent antennas at the receiving station
3-vinylquinolines analogs and methods of synthesizing the derivatives/analogs are provided. In particular, the compounds are useful for the treatment of cancer.
C07D 413/06 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
C07D 401/06 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
96.
Method for robust liquid level control based on artificial time-delay control using IMC feedback
A method and system for set point control of a liquid level in a conical tank is disclosed. The method includes receiving set point signal, R(s), summing the set point signal, R(s), with a negative feedback signal, d{tilde over (f)}(s), and generating set point error signal, E(s), which is used as feedback at the input to drive the liquid level in the conical tank to a desired set point, thus controlling the liquid level of conical tank so that external disturbance, df(s), is minimized.
A speaker identification system and method to identify a speaker based on the speaker's voice is disclosed. In an exemplary embodiment, the speaker identification system comprises a Gaussian Mixture Model (GMM) for speaker accent and dialect identification for a given speech signal input by the speaker and an Artificial Neural Network (ANN) to identify the speaker based on the identified dialect, in which the output of the GMM is input to the ANN.
G10L 17/04 - Training, enrolment or model building
G06N 7/00 - Computing arrangements based on specific mathematical models
G10L 25/21 - Speech or voice analysis techniques not restricted to a single one of groups characterised by the type of extracted parameters the extracted parameters being power information
G10L 25/24 - Speech or voice analysis techniques not restricted to a single one of groups characterised by the type of extracted parameters the extracted parameters being the cepstrum
98.
Wearable stress assessment system with EEG sensors
A method and system that includes a wearable device having a plurality of EEG sensors to detect an EEG signal in a window of a predetermined length, a bandpass filter to remove frequency bands of the EEG signal to obtain a combined signal of remaining frequency bands, and a wireless device connection for wireless transmission of information from the wearable device. The information including the EEG signal and the combined signal. A mobile device includes a communication device for receiving the transmitted information, at least one processor for processing a machine learning model. The machine learning model classifies the combined signal to obtain a classification result of mental stress or not mental stress, and a display device displays a mental stress assessment based on the EEG signal and the classification result.
Beamformers and beamforming methods are disclosed which involve diagonal loading (regularization). Features may include the automatic determination of the regularization parameter using a linearly constrained minimum power (LCMP) bounded perturbation regularization (BPR) approach.
H01Q 3/00 - Arrangements for changing or varying the orientation or the shape of the directional pattern of the waves radiated from an antenna or antenna system
H01Q 3/26 - Arrangements for changing or varying the orientation or the shape of the directional pattern of the waves radiated from an antenna or antenna system varying the relative phase or relative amplitude of energisation between two or more active radiating elementsArrangements for changing or varying the orientation or the shape of the directional pattern of the waves radiated from an antenna or antenna system varying the distribution of energy across a radiating aperture
100.
Bioactive adhesive system compositions and methods of use
A bioactive borate glass adhesive system is described for its composition and use in adhering a plurality of dental restorative components onto a tooth surface. The adhesive system comprises silanated borate bioactive glass particles and a biocompatible resin blend. The bioactive adhesive system functions as a non-degradable, permanent adhesive in tooth restoration in the presence of saliva. In addition, the bioactive borate adhesive system may be used for re-mineralization, de-sensitization and self-healing of dentin and enamel by releasing and depositing calcium and phosphate ions onto the exposed and damaged tooth surface.
patents
